These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prion protein in Caenorhabditis elegans: Distinct models of anti-BAX and neuropathology. Park KW; Li L Prion; 2011; 5(1):28-38. PubMed ID: 21084837 [TBL] [Abstract][Full Text] [Related]
5. Reconstructing prions: fibril assembly from simple yeast to complex mammals. Sigurdson C; Polymenidou M; Aguzzi A Neurodegener Dis; 2005; 2(1):1-5. PubMed ID: 16908997 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional signature of prion-induced neurotoxicity in a Drosophila model of transmissible mammalian prion disease. Thackray AM; Lam B; Shahira Binti Ab Razak A; Yeo G; Bujdoso R Biochem J; 2020 Feb; 477(4):833-852. PubMed ID: 32108870 [TBL] [Abstract][Full Text] [Related]
7. [Mechanisms of neuroinvasion by prions: molecular principles and present state of research]. Brandner S; Klein MA; Aguzzi A Schweiz Med Wochenschr; 2000 Mar; 130(12):435-42. PubMed ID: 10780058 [TBL] [Abstract][Full Text] [Related]
9. In vivo prion models and the disconnection between transmissibility and neurotoxicity. Senesi M; Lewis V; Kim JH; Adlard PA; Finkelstein DI; Collins SJ Ageing Res Rev; 2017 Jul; 36():156-164. PubMed ID: 28450269 [TBL] [Abstract][Full Text] [Related]
10. Acute Neurotoxicity Models of Prion Disease. T Islam AM; Adlard PA; Finkelstein DI; Lewis V; Biggi S; Biasini E; Collins SJ ACS Chem Neurosci; 2018 Mar; 9(3):431-445. PubMed ID: 29393619 [TBL] [Abstract][Full Text] [Related]
11. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity. Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015 [TBL] [Abstract][Full Text] [Related]
12. Sequence-dependent prion protein misfolding and neurotoxicity. Fernandez-Funez P; Zhang Y; Casas-Tinto S; Xiao X; Zou WQ; Rincon-Limas DE J Biol Chem; 2010 Nov; 285(47):36897-908. PubMed ID: 20817727 [TBL] [Abstract][Full Text] [Related]
13. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate. Faburay B; Tark D; Kanthasamy AG; Richt JA Prion; 2014; 8(6):393-403. PubMed ID: 25495764 [TBL] [Abstract][Full Text] [Related]
14. Biology and genetics of prion diseases. Prusiner SB Annu Rev Microbiol; 1994; 48():655-86. PubMed ID: 7826022 [TBL] [Abstract][Full Text] [Related]
15. Prion protein self-interactions: a gateway to novel therapeutic strategies? Rigter A; Langeveld JP; van Zijderveld FG; Bossers A Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496 [TBL] [Abstract][Full Text] [Related]
16. The neuropathological phenotype in transgenic mice expressing different prion protein constructs. DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760 [TBL] [Abstract][Full Text] [Related]
17. The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions. Béland M; Roucou X J Neurochem; 2012 Mar; 120(6):853-68. PubMed ID: 22145935 [TBL] [Abstract][Full Text] [Related]
18. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry. Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021 [TBL] [Abstract][Full Text] [Related]